热门资讯> 正文
赛诺菲完成对Kadmon的收购
2021-11-09 23:04
10:04 AM EST, 11/09/2021 (MT Newswires) -- Sanofi (SAN.PA) on Tuesday completed the acquisition of US biopharmaceutical company Kadmon for a total equity value of around $1.9 billion. The acquisition took place as a merger of Sanofi's unit with and into Kadmon. After the merger, Kadmon remains the surviving company and becomes a subsidiary of Sanofi. Shares of the pharmaceutical company were up 1% on Tuesday afternoon.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
